RotaTeq is vaccine whose goal is to reduce Rota virus infection. Last year there was a concern of intussuception following its administration.
Recent study by the CDC is confirming that RotaTeq is safe based on the 3.6 million doses that has been distributed by Merck & Co.
Physicians should continue to give the vaccine as recommended to infants at two, four, and six months of age.